Research output per year
Research output per year
Prof
Professor of Systems Pharmacology
Director of Centre for Applied Pharmacokinetic Research (CAPKR)
Amin is the Director of the Centre for Applied Pharmacokinetic Research (CAPKR) at the University of Manchester.
The Institute of Scientific Information (ISI, Clativate) listed Amin as one of the world’s most highly cited researchers (under ‘Pharmacology & Toxicology’) in 2017. Amin is at 0.07% top rank of the Highly Cited Researchers List by Stanford University (published by Elsevier) for Pharmacology (2024). He has published over 330 peer reviewed influential scientific articles (>26,500 citations, h-index = 88, Google Scholar) covering various aspects of pharmaceutics, clinical/translational/systems pharmacology.
As the Director of CAPKR since 2017, Amin collaborates with many pharmaceutical companies with a view to transfer latest scientific knowledge into model-informed drug development. Amin was co-founder of two spin-off companies from the University of Sheffield (Simcyp Limited [now part of Certara Inc]) and Diurnal Limited [now part of Neurocrine Bioscience]).
As a leader in the field of physiologically-based pharmacokinetics (PBPK) and Quantitative Systems Pharmacology (QSP), he is internationally recognized and he was one of the founding editors of Pharmacometrics and System Pharmacology in addition to serving on the Editorial Boards of many other pharmacology journals.
In his external appointment, as the Senior Vice President of Research & Development (SVP) and Chief Scientific Officer at Certara since 2014, he facilitates the integration of the latest translational modelling to bio-simulation platforms offered by Certara to its clients, with the aim of accelerating the drug development and regulatory approval.
Professor Rostami has an active program of training PhD students involving proteomics, PBPK, clinical PKPD and precision dosing. Many graduates from his team hold positions in the pharmaceutical industry or academia.
Research Interests
Activities and Distinctions
Centre for Applied Pharmacokinetic Research
1987 - PharmD (Tabriz)
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Chief Scientific Officer, Certara USA Inc
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Research output: Contribution to journal › Article › peer-review
Rostami-Hochaghan, A. (Recipient), 2013
Prize: Fellowship awarded competitively
Rostami-Hochaghan, A. (Recipient), 2011
Prize: Fellowship awarded competitively
Rostami-Hodjegan, A. (Chair), Unadkat, J. D. (Co-Chair), Prasad, B. (Co-Organiser) & Achour, B. (Co-Organiser)
Activity: Participating in or organising event(s) › Organising a conference, workshop, exhibition, performance, inquiry, course etc › Research
Rostami-Hochaghan, A. (Secondee)
Activity: External visiting positions or secondments › Visiting an external non-academic organisation › Research
Rostami-Hochaghan, A. (Secondee)
Activity: External visiting positions or secondments › Visiting an external non-academic organisation › Research
Rostami-Hochaghan, A. (Academic founder)
Activity: Consultancy, spin-outs, CPD & licensing › Consultancy & Services › Research
Rostami-Hochaghan, A. (Academic expert member)
Activity: Membership › Membership of board › Research
Rostami-Hochaghan, A. (Participant), Aarons, L. (Participant), Galetin, A. (Participant), Barber, J. (Participant), Ogungbenro, K. (Participant) & Darwich, A. (Participant)
Impact: Technological impacts, Economic, Health and wellbeing, Policy
Rostami-Hochaghan, A. (Participant)
Impact: Cultural impacts, Economic impacts, Health impacts, Political impacts, Technological impacts